Bifidobacterium modulation of tumor immunotherapy and its mechanism

Bo Pei,Shixuan Peng,Chuying Huang,Fuxiang Zhou,Zhou, Fuxiang

DOI: https://doi.org/10.1007/s00262-024-03665-x

IF: 6.63

2024-04-03

Cancer Immunology Immunotherapy

Abstract:The advent of tumor immunotherapy in patients has revolutionized the treatment of tumors and significantly improved survival rates for a wide range of tumors. However, the full therapeutic potential of immune checkpoint inhibitors (ICIs) has yet to be realized, as not all patients have a lasting survival benefit from them, and a significant proportion of patients show primary or acquired resistance to immunotherapy. Bifidobacterium is one of the most common probiotics, and its antitumor and immunomodulatory effects have been demonstrated in recent years, but its immunomodulatory effects in tumors, especially on ICIs and in combination, have not been extensively studied in clinical practice, and its effects on the immune system and the mechanisms that modulate immunotherapy are largely unknown. Therefore, this review will focus on the immunomodulatory effects of Bifidobacteria in malignancies and the possible mechanisms of action of Bifidobacteria on immunotherapy in the hope of providing a basis for further research and better application of Bifidobacteria in clinical practice.

oncology,immunology

What problem does this paper attempt to address?

The problem this paper attempts to address is the immunomodulatory role and mechanisms of Bifidobacterium in tumor immunotherapy. Specifically, the paper focuses on the following aspects:

1. **Enhancement of Immune Checkpoint Inhibitors (ICIs) Efficacy**: Although immune checkpoint inhibitors have shown significant therapeutic effects in various tumors, not all patients benefit from them, and some patients develop primary or acquired resistance. Therefore, the study aims to explore how Bifidobacterium can enhance the efficacy of immune checkpoint inhibitors and improve patient survival rates.

2. **Immunomodulatory Role of Bifidobacterium**: Bifidobacterium, as a common probiotic, has been proven to have anti-tumor and immunomodulatory effects, but the research on its immunomodulatory mechanisms in clinical practice is still insufficient. The paper explores the specific mechanisms of Bifidobacterium in tumor immunotherapy, including activating the immune system, affecting gut microbiota metabolism, and inducing tumor cell apoptosis.

3. **Clinical Application Prospects**: By deeply studying the immunomodulatory mechanisms of Bifidobacterium, the paper hopes to provide a theoretical basis for future research and promote the clinical application of Bifidobacterium in tumor immunotherapy. For example, by supplementing specific strains of Bifidobacterium to improve the patient's gut microecology, thereby enhancing the effect of immunotherapy.

In summary, this review paper aims to comprehensively explore the mechanisms of Bifidobacterium in tumor immunotherapy, with the hope of providing new strategies to improve the efficacy of immunotherapy.